Literature DB >> 22916844

High frequency of CYP2C19*2 carriers in PCI-treated patients switched over from clopidogrel to prasugrel based on platelet function monitoring.

Isabell Bernlochner, Katharina Mayer, Tanja Morath, Siegmund Braun, Stefanie Schulz, Albert Schömig, Werner Koch, Adnan Kastrati, Dirk Sibbing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22916844     DOI： 10.3109/09537104.2012.715218

Source DB:  PubMed          Journal:  Platelets        ISSN： 0953-7104            Impact factor:   3.862


× No keyword cloud information.
  1 in total

1.  A randomized controlled trial to assess the efficacy and safety of doubling dose clopidogrel versus ticagrelor for the treatment of acute coronary syndrome in patients with CYP2C19*2 homozygotes.

Authors:  Ran Xiong; Wenxian Liu; Liying Chen; Tieduo Kang; Shangqiu Ning; Jiang Li
Journal:  Int J Clin Exp Med       Date:  2015-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.